VALIANT LABORATORIES LTD. Fact Sheet
(VALI)
More on VALIANT LABORATORIES LTD.
-
Here is the latest financial fact sheet of VALIANT LABORATORIES LTD.. For more details, see the VALIANT LABORATORIES LTD. quarterly results and VALIANT LABORATORIES LTD. share price. For a sector overview, read our pharmaceuticals sector report.
VALIANT LABORATORIES LTD. Price History
Price |
Rs |
139.8 |
Mkt Cap |
Rs m |
6,072 |
Vol |
'000 |
15.2 |
P/E |
X |
|
P/CF |
X |
19.9 |
EPS (TTM) |
Rs |
0.0 |
1 Day |
% |
-1.4 |
No. of shares |
m |
43.45 |
1 Week |
% |
-0.3 |
1 Month |
% |
-11.7 |
1 Year |
% |
- |
52 week H/L |
Rs |
227.0/138.5 |
As on May 30, 2024 (Close)
* Results Consolidated
VALIANT LABORATORIES LTD. Financials
No. of Mths
Year Ending |
12
Mar-22* |
12
Mar-23* |
5-Yr Chart
Click to enlarge
|
VALIANT LABORATORIES LTD. EQUITY SHARE DATA |
High
|
Rs | NA | NA |
|
Low
|
Rs | NA | NA |
|
Sales per share (Unadj.)
|
Rs | 179.1 | 102.6 |
|
Earnings per share (Unadj.)
|
Rs | 16.9 | 8.9 |
|
Diluted earnings per share | Rs | 6.3 | 6.7 | |
Cash flow per share (Unadj.)
|
Rs | 18.4 | 9.4 |
|
Dividends per share (Unadj.)
|
Rs | 0 | 0 |
|
Adj. dividends per share | Rs | 0.00 | 0.00 | |
Avg Dividend yield
|
% | 0 | 0 |
|
Book value per share (Unadj.)
|
Rs | 43.9 | 30.9 |
|
Adj. book value per share | Rs | 16.4 | 23.1 | |
Shares outstanding (eoy)
|
m | 16.28 | 32.56 |
|
Bonus / Rights / Conversions
|
| 0 | 0 |
|
Price / Sales ratio
|
x | 0 | 0 |
|
Avg P/E ratio
|
x | 0 | 0 |
|
P/CF ratio (eoy)
|
x | 0 | 0 |
|
Price / Book Value ratio
|
x | 0 | 0 |
|
Dividend payout
|
% | 0 | 0 |
|
Avg Mkt Cap
|
Rs m | 0 | 0 |
|
No. of employees
|
`000 | NA | NA |
|
Total wages/salary
|
Rs m | 31 | 46 |
|
Avg. sales/employee
|
Rs Th | 0 | 0 |
|
Avg. wages/employee
|
Rs Th | 0 | 0 |
|
Avg. net profit/employee
|
Rs Th | 0 | 0 |
|
VALIANT LABORATORIES LTD. INCOME DATA |
Net Sales
|
Rs m | 2,915 | 3,339 |
|
Other income
|
Rs m | 19 | 49 |
|
Total revenues
|
Rs m | 2,935 | 3,388 |
|
Gross profit
|
Rs m | 423 | 351 |
|
Depreciation
|
Rs m | 25 | 16 |
|
Interest
|
Rs m | 1 | 3 |
|
Profit before tax
|
Rs m | 417 | 381 |
|
Minority Interest
|
Rs m | 0 | 0 |
|
Prior Period Items
|
Rs m | 0 | 0 |
|
Extraordinary Inc (Exp)
|
Rs m | 0 | 0 |
|
Tax
|
Rs m | 142 | 91 |
|
Profit after tax
|
Rs m | 275 | 290 |
|
Gross profit margin
|
% | 14.5 | 10.5 |
|
Effective tax rate
|
% | 34.1 | 24.0 |
|
Net profit margin
|
% | 9.4 | 8.7 |
|
VALIANT LABORATORIES LTD. BALANCE SHEET DATA |
Current assets
|
Rs m | 1,568 | 1,506 |
|
Current liabilities
|
Rs m | 494 | 507 |
|
Net working cap to sales
|
% | 36.8 | 29.9 |
|
Current ratio
|
x | 3.2 | 3.0 |
|
Inventory Days
|
Days | 2 | 52 |
|
Debtors Days
|
Days | 139 | 97 |
|
Net fixed assets
|
Rs m | 250 | 624 |
|
Share capital
|
Rs m | 163 | 326 |
|
"Free" reserves
|
Rs m | 552 | 679 |
|
Net worth
|
Rs m | 715 | 1,005 |
|
Long term debt
|
Rs m | 594 | 594 |
|
Total assets
|
Rs m | 1,818 | 2,130 |
|
Interest coverage
|
x | 572.3 | 151.1 |
|
Debt to equity ratio
|
x | 0.8 | 0.6 |
|
Sales to assets ratio
|
x | 1.6 | 1.6 |
|
Return on assets
|
% | 15.2 | 13.7 |
|
Return on equity
|
% | 38.5 | 28.9 |
|
Return on capital
|
% | 31.9 | 24.0 |
|
Exports to sales
|
% | 0 | 0 |
|
Imports to sales
|
% | 0 | 0 |
|
Exports (fob) |
Rs m | 0 | 0 | |
Imports (cif) |
Rs m | 0 | 0 | |
Fx inflow |
Rs m | 0 | 0 | |
Fx outflow |
Rs m | 0 | 0 | |
Net fx |
Rs m | 0 | 0 | |
VALIANT LABORATORIES LTD. CASH FLOW |
From Operations |
Rs m | 23 | 561 | |
From Investments |
Rs m | -122 | -552 | |
From Financial Activity |
Rs m | 62 | -9 | |
Net Cashflow |
Rs m | -38 | -1 | |
* Results Consolidated
Source: Accord Fintech, Equitymaster
Share Holding
Promoters |
74.9% |
Institution |
3.5% |
Non-Institution |
21.6% |
Total |
100.0% |
Free Float |
25.1% |
Pledged promoter holdings |
0.0% |
Shareholding as on Mar 2024
|
|
Company Information
Regd Off |
104 Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai - 400080 |
E-mail |
complianceofficer@valiantlabs.in |
Web |
www.valiantlabs.in |
Tel |
022-49712001 |
Fax |
|
Sector |
PHARMACEUTICALS |
Group |
Private sector |
Tr Agent |
Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West) |
|
CHM: Velji Gogri |
COMP SEC: Prajakta Patil |
YEAR OF INC: 2021 |
BSE CODE: 543998 |
FV (Rs): 10 |
DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets:
DIVIS LABORATORIES DR. REDDYS LAB CIPLA ZYDUS LIFESCIENCES SUN PHARMA
Compare VALIANT LABORATORIES LTD. With:
DIVIS LABORATORIES DR. REDDYS LAB CIPLA ZYDUS LIFESCIENCES SUN PHARMA
Today's Market
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.